Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population

Abstract

Purpose: Unpredictable drug efficacy and safety of combined antiepileptic therapy is a major challenge during pharmacotherapy decisions in everyday clinical practice. The aim of this study was to describe the pharmacokinetics of valproic acid (VA), lamotrigine (LTG), and levetiracetam (LEV) in a pediatric population using nonlinear mixed-effect modeling, while machine learning (ML) algorithms were applied to identify any relationships among the plasma levels of the three medications and patients’ characteristics, as well as to develop a predictive model for epileptic seizures. Methods: The study included 71 pediatric patients of both genders, aged 2–18 years, on combined antiepileptic therapy. Population pharmacokinetic (PopPK) models were developed separately for VA, LTG, and LEV. Based on the estimated pharmacokinetic parameters and the patients’ characteristics, three ML approaches were applied (principal component analysis, factor analysis of mixed data, and random forest). PopPK models and ML models were developed, allowing for greater insight into the treatment of children on antiepileptic treatment. Results: Results from the PopPK model showed that the kinetics of LEV, LTG, and VA were best described by a one compartment model with first-order absorption and elimination kinetics. Reliance on random forest model is a compelling vision that shows high prediction ability for all cases. The main factor that can affect antiepileptic activity is antiepileptic drug levels, followed by body weight, while gender is irrelevant. According to our study, children’s age is positively associated with LTG levels, negatively with LEV and without the influence of VA. Conclusion: The application of PopPK and ML models may be useful to improve epilepsy management in vulnerable pediatric population during the period of growth and development.

Application of machine learning combined with population pharmacokinetics to improve individual prediction of vancomycin clearance in simulated adult patients

“…In pharmacokinetics, machine learning allows for analysis and prediction ( Ota and Yamashita, 2022 ; Wang et al, 2023 ). The combination of machine learning and population pharmacokinetics is a new tool for drug research and development ( Zhu et al, 2022 ; Damnjanovic et al, 2023 ). It has been reported that machine learning combined with PPK method can improve the prediction of individual clearance of six drugs in neonates ( Tang et al, 2021 ).…”

Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin

“…The quality of the prediction of individual drug concentrations has a crucial impact on finding the optimal dosage regimen and, eventually, on therapeutic success. Interest Pharmaceutics 2024, 16, 358 2 of 19 in augmenting pharmacokinetic models with the help of machine learning algorithms has recently increased because the construction of models which efficiently represent a broader set of patients has often proved to be an overwhelming task, especially in pediatric populations, as well as in populations diagnosed with rare diseases, or living with special conditions (e.g., oncological and organ-transplant recipients, or patients receiving intensive care) [6][7][8][9]. Augmented pop-PK models are expected to overcome the limitations posed by the availability of a low number of subjects and/or data points, and may therefore facilitate the implementation of MIPD [10].…”

Improving prediction of tacrolimus concentration using a combination of population pharmacokinetic modeling and machine learning in chinese renal transplant recipients

“…Despite the higher accuracy of ML algorithms, there are some limitations to this strategy, such as inexplicable results (Destere et al, 2023). It can be assumed that a proper combination of two methods may provide more reliable predictions (Damnjanović et al, 2023). This study aimed to establish a model of TAC ML combined with PPK in Chinese patients undergoing renal transplantation.…”